Literatura académica sobre el tema "Paracetamolo"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Paracetamolo".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Paracetamolo"
Rossi, A., D. Palombo, V. Capilupi y M. Chiapasco. "Pancreatite acuta secondaria a somministrazione di paracetamolo e codeina dopo trattamento odontoiatrico. Analisi della letteratura e caso clinico". Dental Cadmos 84, n.º 5 (mayo de 2016): 304–12. http://dx.doi.org/10.1016/s0011-8524(16)30065-4.
Texto completoHinz, Burkhard y Kay Brune. "Paracetamol and cyclooxygenase inhibition: is there a cause for concern?" Annals of the Rheumatic Diseases 71, n.º 1 (28 de octubre de 2011): 20–25. http://dx.doi.org/10.1136/ard.2011.200087.
Texto completoComan, Laurențiu, Horia Păunescu, Cristina Isabel Viorica Ghiță, Radu Ciprian Țincu, Sorina Vasile, Delia Cinteza, Ion Fulga y Oana Andreia Coman. "Paracetamol-Induced Hypothermia in Rodents: A Review on Pharmacodynamics". Processes 10, n.º 4 (31 de marzo de 2022): 687. http://dx.doi.org/10.3390/pr10040687.
Texto completoBegum, Shaheen, Poojitha Harisree G y Rashida Anjum M S. "A Short Review on Biological Activities of Paracetamol Derivatives". International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN) 16, n.º 1 (13 de febrero de 2023): 6309–25. http://dx.doi.org/10.37285/ijpsn.2023.16.1.5.
Texto completoOestmann, Andreas y Annika Stöppler. "Die saure Patientin". Praxis 108, n.º 4 (abril de 2019): 283–85. http://dx.doi.org/10.1024/1661-8157/a003201.
Texto completoHamed Almurisi, Samah, Khater AL-Japairai, Farhan Alshammari, Fawaz Alheibshy, Rana M. F. Sammour y Abd Almonem Doolaanea. "Stability of Paracetamol Instant Jelly for Reconstitution: Impact of Packaging, Temperature and Humidity". Gels 8, n.º 3 (25 de febrero de 2022): 144. http://dx.doi.org/10.3390/gels8030144.
Texto completoMohamed, Ashma, Alexa Wacker y Martin Schmidt. "Chronic Misuse of Paracetamol in OCD Without Hepatic Injury: A Case Report and Literature Review". BJPsych Open 8, S1 (junio de 2022): S123. http://dx.doi.org/10.1192/bjo.2022.364.
Texto completoAmirul Fauziah, Dewi rashati,. "PENGARUH VARIASI KONSENTRASI AMILUM Zea mays (L) SEBAGAI BAHAN PENGHANCUR SECARA GRANULASI BASAH TERHADAP SIFAT FISIK TABLET PARASETAMOL". JURNAL ILMIAH FARMASI AKADEMI FARMASI JEMBER 2, n.º 1 (28 de enero de 2021): 1–6. http://dx.doi.org/10.53864/jifakfar.v2i1.15.
Texto completoRahimi, Omid, Nilufar Asadi Louie, Alireza Salehi y Firouz Faed Maleki. "Hepatorenal Protective Effects of Hydroalcoholic Extract of Solidago canadensis L. against Paracetamol-Induced Toxicity in Mice". Journal of Toxicology 2022 (17 de diciembre de 2022): 1–11. http://dx.doi.org/10.1155/2022/9091605.
Texto completoMystakidou, MD, PhD, Kyriaki, Emmanuela Katsouda, MD, PhD, Vassilios Kouloulias, MD, PhD, John Kouvaris, MD, PhD, Marinos Tsiatas, MD y Lambros Vlahos, MD, PhD. "Comparison of transdermal fentanyl with codeine/paracetamol, in combination with radiotherapy, for the management of metastatic bone pain". Journal of Opioid Management 1, n.º 4 (1 de septiembre de 2005): 204. http://dx.doi.org/10.5055/jom.2005.0044.
Texto completoTesis sobre el tema "Paracetamolo"
Rivalta, Arianna. "Il polimorfismo del paracetamolo: indagine mediante spettroscopia Raman e metodi computazionali". Master's thesis, Alma Mater Studiorum - Università di Bologna, 2016. http://amslaurea.unibo.it/11169/.
Texto completoRancan, Elia <1987>. "Sintesi del paracetamolo e altre ammidi di interesse industriale mediante riarrangiamenti organo catalizzati da CF3COOH". Master's Degree Thesis, Università Ca' Foscari Venezia, 2013. http://hdl.handle.net/10579/2754.
Texto completoElijošius, Evaldas. "Kramtomųjų paracetamolio tablečių vaikams technologija". Master's thesis, Lithuanian Academic Libraries Network (LABT), 2011. http://vddb.laba.lt/obj/LT-eLABa-0001:E.02~2011~D_20110628_155329-47227.
Texto completoOn this time in Lithuania we don‘t have enough medicinal drug forms for children, which are made by industrial methods (we collated all registred drug forms for children, which are in Lithuania‘s drugs registration list). After long science studies, we decided to create the chewabe tablets for children manufacturing technology. First of all we collected information about all possible tablets manufacturing technology variants, collected information about paracetamol and supplementary materials. We have learned about granulation methods and tablet manufacturing variants. Was established powder tachnological characteristics. Selected supplementary materials and it‘s count, that would let us to create tablets by wet granuliating. Tablets was pressed by eccentric tablet machine „Diaf“. Was made 330 mg average mass, regular form, with flat edges tablets. Its have soft smooth surface, 9 mm diameter, 3 mm height. Data set about tablets quality by European Pharmacopoeia requirements: tablets strength for abrasion, strength for pressure, average tablets mass, tablets disintegration and tablets dissolution. We accomplished tablets stability tests. Accomplished studies have shown, that we could make chewable paracetamol tablets for children by selected technology. Those tablets passes through all European Pharmacopoeia requirements.
Ciegis, Paulius. "Alprazolamo, kodeino ir paracetamolio mišinio kokybinė analizė plonasluoksnės ir efektyviosios skysčių chromatografijos metodais". Master's thesis, Lithuanian Academic Libraries Network (LABT), 2014. http://vddb.library.lt/obj/LT-eLABa-0001:E.02~2014~D_20140618_233534-96441.
Texto completoAim: To optimize thin-layer chromatography and high-performance liquid chromatography methods for alprazolam, codeine, paracetamol and their mixture qualitative analysis. Object and methods: For TLC method optimization alprazolam, codeine, paracetamol and their mixture stock solutions (0,2 mg/ml) in trichlormetan were analysed. For mobile phase were used: ethanol, trichlormetan, ether, 25% ammonia hydroxide, acetone, isobutanol. For spots development were used UV light lamp (254nm; 365nm) or Dragendorff reagent (modified by Munje). Optimized methods were tried with pharmaceutical products “Xanax”, “Paracetamolis Sanitas” and “Ultracod” solutions. For HPLC method optimization alprazolam, codeine, paracetamol and their mixture stock solutions (0,1 mg/ml) in methanol were analysed. Chromatograph Waters 2695 with photo diode array detector Waters 996 (210-400 nm wave length) were used for qualitative determination. Analysis was made by using methanol and 3% acetic acid aqueous solution. Optimized method was applied in analysis of pharmaceutical products “Xanax”, “Ultracod” and “Solpadeine” solutions. Results: The best mobile phases for alprazolam, codeine and paracetamol mixture qualitative analysis using TLC is TS-D (trichlormetan: acetone: concentrated ammonia hydroxide (55:40:5)) and TS-F (trichlormetan: ether: isobutanol: concentrated ammonia hydroxide (50:30:15:5)). TS-D and TS-F mobile phases are suitable for examined substances qualitative analysis in mixture and... [to full text]
Mohd, Zaki Hamizah. "Spectroscopy surface analysis of paracetamol and paracetamol and excipient systems". Thesis, University of Manchester, 2011. https://www.research.manchester.ac.uk/portal/en/theses/spectroscopy-surface-analysis-of-paracetamol-and-paracetamol-and-excipient-systems(2f50af69-fb35-487b-8065-46aa3c86f96c).html.
Texto completoCastro, Pedro Luís Pereira de. "Farmacocinética do paracetamol". Master's thesis, [s.n.], 2014. http://hdl.handle.net/10284/4415.
Texto completoO paracetamol é um dos analgésicos e antipiréticos mais utilizados em crianças e adultos por possuir uma janela terapêutica larga com poucos efeitos adversos. No entanto, por ser um medicamento não sujeito a receita médica, é por vezes utilizado em sobredosagem, podendo provocar hepatotoxicidade decorrente do esgotamento dos níveis de glutationa hepática e do excesso de produção de N-acetil-p-benzoquinonaimina (NAPQI), um metabolito alquilado, que se liga aos grupos sulfidrilo das proteínas hepáticas originando necrose dos hepatócitos. Com vista a descrever o comportamento deste fármaco num organismo e determinar a influência de fatores como o síndrome de Gilbert, o jejum, o alcoolismo e a administração de doses supraterapêuticas na sua ação terapêutica e possível toxicidade têm sido sugeridos diversos modelos farmacocinéticos compartimentais e fisiológicos. Nesta dissertação é apresentada uma revisão bibliográfica, organizada cronologicamente, dos modelos que, em virtude da informação cinética e dinâmica que fornecem, são considerados mais relevantes. Um dos modelos mais completos e importantes foi o proposto em 2013 por Pery e colaboradores. Trata-se de um modelo de base fisiológica que permitiu estudar a distribuição e caraterizar a hepatotoxicidade de uma dose supraterapêutica de paracetamol. Dada a sua relevância e atualidade, este modelo foi analisado em maior detalhe tendo sido simulado em Microsoft Excel®. Os resultados obtidos mostram que após administração de uma dose supraterapêutica de paracetamol pode ocorrer saturação das reações de fase II no fígado (sulfatação e de glucuronidação), verificando-se a presença de elevadas concentrações de paracetamol inalterado no organismo, podendo-se associar a este factor, a formação de quantidades elevadas de NAPQI. Pery et al., a partir dos resultados obtidos numa simulação idêntica, juntamente com extrapolações realizadas com softwares especializados, previram que a dose para qual seria de esperar efeitos significativos na viabilidade celular no Homem, seria de 155 mg/kg. Paracetamol is one of the most widely used analgesics and antipyretics in children and adults by having a wide therapeutic window with few adverse effects. However because it is an over-the-counter (OTC) drug, is sometimes used in overdose and may cause hepatotoxicity resulting from the depletion of hepatic glutathione levels and excessive production of N-acetyl-p-benzoquinoneimine (NAPQI), an alkylated metabolite which binds to sulfhydryl groups of hepatic proteins leading to necrosis of the hepatocytes. Many compartimental and physiologically based pharmacokinetic models have been suggested to describe the pharmacokinetics of paracetamol and to determine how fators such as the Gilbert syndrome, fasting, alcoholism and supratherapeutic dosages influence the therapeutic action and toxicity of the molecule. This thesis presents a literature review of how the pharmacokinetics of paracetamol has been studied. References were selected and organized chronologically and according to the dynamic or kinetic information they provide, in order to expose the different pharmacokinetic models that have been proposed, clarify their application and limitations. One of the most complete and important models was the one proposed by Pery et al. in 2013. It is a physiologically based model which enabled to study the distribution and characterize the hepatotoxicity of a supratherapeutic dosage of paracetamol. Given its relevance and topicality, this model was analyzed in further detail being simulated in Microsoft Excel®. The results obtained indicate that, when a supratherapeutic paracetamol is administered, there can be a saturation of phase II reactions in liver (sulfonation and glucoronidation) and high concentrations of unchanged paracetamol in several organs that may be associated with the formation of high concentrations of NAPQI. From the results of a similar simulation, together with extrapolations perfomed with specialized softwares, Pery et al. predicted that the dosage which could lead to significant effects on cell viability in humans would be 155 mg/kg.
Robinson, D. "Factors influencing paracetamol overdose". Thesis, Queen's University Belfast, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.403484.
Texto completoFlodell, Amanda. "Risker vid användning av paracetamol under graviditet : Risker vid användning av paracetamol under graviditet". Thesis, Umeå universitet, Kemiska institutionen, 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-102007.
Texto completoCabral, Flavia Helena Costa. "Alterações morfologicas testiculares provocadas pelo cadmio, paracetamol e cadmio associado ao paracetamol, em ratos". [s.n.], 1996. http://repositorio.unicamp.br/jspui/handle/REPOSIP/317850.
Texto completoDissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia
Made available in DSpace on 2018-07-21T09:40:36Z (GMT). No. of bitstreams: 1 Cabral_FlaviaHelenaCosta_M.pdf: 7932022 bytes, checksum: 5df8caed27891d2ed2c74e69d6748a6b (MD5) Previous issue date: 1996
Resumo: O cádmio é um elemento químico, reconhecido atualmente como perigoso devido sua alta toxicidade e os efeitos deletérios que provoca nos seres vivos. Recentemente também tem sido investigadas com maior interesse e atenção, algumas drogas vendidas sem prescrições médicas como por ex. o paracetamol, cujos efeitos tóxicos são pouco informados aos usuários. O presente trabalho tem por objetivos analisar e avaliar os efeitos do cádmio (sob forma de CdCI2.H20), do paracetamol (na forma de Tylenol @ - gotas) e destas substâncias administradas simultaneamente, sobre os testículos de ratos. Neste estudo foram utilizados 44 ratos, do sexo masculino (adultos-jovens) da linhagem Wistar. Realizaram-se estudos histológicos qualitativos e quantitativos à microscopia de luz. Os animais foram submetidos à diferentes dosagens do cádmio (2,5; 7,5; 10 e 15 IJmols I kg), do paracetamol (4,4 e 8,8 mmols I kg) e do cádmio associado ao paracetamol (2,5 IJmols I kg + 4,4 mmols I kg; 7,5 IJmols I kg + 8,8 mmols I kg; 15 IJmols I kg + 8,8 mmols I kg). As observações histológicas revelaram, para os animais submetidos ao cádmio nas doses de. 10 IJmols I kg (com duração de 83 dias) ou 15 IJmols I kg (duração de 06 dias), alterações morfológicas graves em todo o parênquima testicular. Estas alterações são caracterizadas por necrose coagulativa do epitélio seminífero, espessamento da túnica albugínea e degeneração do tecido intersticial. Para os animais tratados com 15 IJmols I kg, houve perda de peso corporal e os resultados quantitativos demonstram valores significativos pela redução dos diâmetros de túbulos seminíferos. Para. os animais tratados com 10 Jjmols I kg, os resultados qualitativos revelaram uma diminuição dos pesos testiculares. Nas doses do cádmio com 2,5 e 7,5 Jjmols I kg e do paracetamol com 4,4 e 8,8 mmols I kg respectivamente, não se observou efeitos lesivos graves nos testículos dos animais investigados. Entretanto quando estas duas substâncias foram administradas simultaneamente, observou-se o efeito aditivo que provocou alterações testiculàres, detectadas à microscopia de luz. A administração do cádmio (7,5 e 15 Jjmols I kg) com o paracetamol (8,8 mmols I kg), leva a uma potencialização dos efeitos deletérios, sendo evidenciada pela redução altamente significativa dos diâmetros dos túbulos seminíferos
Abstract: Cadmium is a chemical element recognized today as dangerous due to its high toxicity and harmful effects toward life. Also recently, drugs sold freely without prescription, such as paracetamol, are being investigated for their toxic effects, of which the public is frequently not aware. This study was undertaken to analyse and evaluate the effects on rat testicles of cadmuim (CdCI2.H20), of paracetamol (in the form of Tylenol @ drops) and of these two substances administered simultaneously. For this work, 44 male rats (young adults) of the Wistar lineage were used. Quantitative and qualitativ.e evaluations were made with light microscopy. The animais received various dosages of cadmium (2.5, 7.5,10 and 15 I-Imols I kg), of paracetamol (4.4 and 8.8 mmols I kg) and of cadmium associated with paracetamol (2.5 I-Imols I kg + 4.4 mmols I kg; 7.5 I-Imols I kg + 8.8 mmols I kg; 15 I-Imols I kg + 8.8 mmols I kg). Histological observations showed severe alterations of the testicles for animais that received cadmium in the dose of 10 I-Imols I kg (followed for a 83 day period) or 15 I-Imols I kg (for 06 days). These alterations were classified as coagulative necrosis of the seminal epithelium, tunica albuginea thickening and degeneration of the interstitial tissue. Animais treated with 15 I-Imols I kg lost body weight and the reduction in diameter of the seminal tubules was highly significant. Animais which received 10 I-Imols I kg had a reduction in weight of their testicles. In the cadmium doses of 2.5 and 7.5 I-Imols I kg and of paracetamol in doses of 4.4 and 8.8 mmols I kg no serious lesions were encountered in the animais studied. However, when these substances were administered simultaneously, an additive effect was shown to cause slight. testicular alterations, observed with the light microscope. Higher cadmium doses (7.5 and 15 I-Imols I kg) and the larger paracetamol dose (8.8 mmols I kg) resulted in a potentiation of the harmful effects, measured by the highly significant reduction _n diameter of the seminal tubules
Mestrado
Biologia Celular
Mestre em Ciências Biológicas
Chiew, Angela. "Changing paradigms of paracetamol poisoning". Thesis, University of Sydney, 2020. https://hdl.handle.net/2123/23382.
Texto completoLibros sobre el tema "Paracetamolo"
J, Meredith T., World Health Organization, Commission of the European Communities. y International Program on Chemical Safety., eds. Antidotes for poisoning by paracetamol. Cambridge: Published by Cambridge University Press on behalf of the World Health Organization and of the European Commission, 1995.
Buscar texto completoParacetamol (acetaminophen): A critical bibliographic review. 2a ed. London: Taylor & Francis, 2001.
Buscar texto completoParacetamol (acetaminophen): A critical bibliographic review. London, UK: Taylor & Francis, 1996.
Buscar texto completoN, Gregg y Great Britain. Health and Safety Executive., eds. Paracetamol: Criteria document for an occupational exposure limit. London: HSE Books, 1994.
Buscar texto completoEn Prozac is mijn paracetamol: Zestien en depressief. [Schiedam]: Scriptum, 2010.
Buscar texto completoRicardo, Royder Yáñez y Cruz Catata Teodora, eds. Mentisán, paracetamol o wira wira?: Jóvenes, salud e interculturalidad en los barrios mineros de Potosí. La Paz: PIEB, Programa de Investigación Estratégica en Bolivia, 2006.
Buscar texto completoNational Register of Foreign Collaborations (India) y India. Dept. of Scientific & Industrial Research., eds. Technology in Indian paracetamol industry: A status report prepared under the National Register of Foreign Collaborations. New Delhi: Govt. of India, Dept. of Scientific & Industrial Research, Ministry of Science and Technology, 1994.
Buscar texto completoParacetamol. Royal Society of Chemistry, 2002.
Buscar texto completoJoe, Smith. Paracetamol. Independently Published, 2018.
Buscar texto completoexecutive, Health and safety. Paracetamol. Health and Safety Executive (HSE), 1994.
Buscar texto completoCapítulos de libros sobre el tema "Paracetamolo"
McAllister-Williams, R. Hamish, Daniel Bertrand, Hans Rollema, Raymond S. Hurst, Linda P. Spear, Tim C. Kirkham, Thomas Steckler et al. "Paracetamol". En Encyclopedia of Psychopharmacology, 952. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-68706-1_7004.
Texto completoBeyer, Karl-Heinz. "Paracetamol". En Biotransformation der Arzneimittel, 419–23. Berlin, Heidelberg: Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-74386-3_242.
Texto completoVidal, C. y W. R. Külpmann. "Paracetamol". En Lexikon der Medizinischen Laboratoriumsdiagnostik, 1–2. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-49054-9_2343-1.
Texto completoVidal, C. y W. R. Külpmann. "Paracetamol". En Springer Reference Medizin, 1820–21. Berlin, Heidelberg: Springer Berlin Heidelberg, 2019. http://dx.doi.org/10.1007/978-3-662-48986-4_2343.
Texto completoSchneider, Achim, Günther Schlunck y Viola Sieber. "Paracetamol". En Geburtshilfefibel, 284–85. Berlin, Heidelberg: Springer Berlin Heidelberg, 1991. http://dx.doi.org/10.1007/978-3-642-97317-8_66.
Texto completoBateman, D. Nicholas. "Acetaminophen (Paracetamol)". En Critical Care Toxicology, 1–25. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-20790-2_108-1.
Texto completoBateman, D. Nicholas. "Acetaminophen (Paracetamol)". En Critical Care Toxicology, 1–25. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-20790-2_108-2.
Texto completoWilson, John Fawcett. "Paracetamol (Acetaminophen)". En The Immunoassay Kit Directory, 1572–73. Dordrecht: Springer Netherlands, 1995. http://dx.doi.org/10.1007/978-94-011-0679-5_38.
Texto completoBateman, D. Nicholas. "Acetaminophen/Paracetamol". En Critical Care Toxicology, 1145–69. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-17900-1_108.
Texto completoGinat, Daniel Thomas. "Acetominophen (Tylenol, Paracetamol)". En Neuroimaging Pharmacopoeia, 341–45. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-12715-6_49.
Texto completoActas de conferencias sobre el tema "Paracetamolo"
Malia, R. G., H. J. Kennedy, D. R. Triger y F. E. Preston. "PROTECTIVE EFFECT OF VITAMIN K AGAINST ACETAMINOPHEN (PARACETAMOL) TOXICITY IN THE HAMSTER". En XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644341.
Texto completoHidayati, Ika Ratna, Elys Oktaviana, Irma Nurtiana Syafitri y Liza Pristianty. "Knowledge Levels and Paracetamol Self-Medication". En Health Science International Conference (HSIC 2017). Paris, France: Atlantis Press, 2017. http://dx.doi.org/10.2991/hsic-17.2017.42.
Texto completoMeng, Cui, Ruijuan Qu, Jinyan Liang, Xi Yang, Fangming Jin, Qi Zhou y Bing Wu. "Photodegradation of Paracetamol in Nitrate Solution". En 2nd International Symposium on Aqua Science, Water Resource and Low Carbon Energy. AIP, 2010. http://dx.doi.org/10.1063/1.3529338.
Texto completoManzotti de Souza, Fernando, Gabriela Nascimento Silva, Melissa Gurgel Adeodato Vieira y Onélia Aparecida Andreo dos Santos. "Adsorção de Paracetamol em Argilas Bentoníticas Organomodificadas". En Simpósio de Bioquímica e Biotecnologia. Londrina - PR, Brazil: Galoa, 2017. http://dx.doi.org/10.17648/simbbtec-2017-80793.
Texto completoCrook, J., H. Yorke y R. Cooper. "G107(P) Reducing paracetamol medication errors in children". En Royal College of Paediatrics and Child Health, Abstracts of the RCPCH Conference–Online, 25 September 2020–13 November 2020. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2020. http://dx.doi.org/10.1136/archdischild-2020-rcpch.84.
Texto completoMagnus, Maria Christine, Øystein Karlstad, Siri Eldevik Håberg, Per Nafstad, George Davey Smith y Wenche Nystad. "Prenatal and infant paracetamol exposure and development of asthma". En Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.oa4766.
Texto completoCheng, E. M., M. Fareq, F. S. Abdullah, F. H. Wee, S. F. Khor, Y. S. Lee, M. Afendi et al. "Dielectric spectroscopy of pharmaceutical drug (Paracetamol) dosage in water". En 2013 IEEE International RF and Microwave Conference (RFM). IEEE, 2013. http://dx.doi.org/10.1109/rfm.2013.6757295.
Texto completoMeguya, Ryu, Soon Hock Ng, Jitraporn Vongsvivut, Mark J. Tobin, Junko Morikawa y Saulius Juodkazis. "Orientation information added to IR hyperspectral imaging: silk and paracetamol". En Biophotonics Australasia 2019, editado por Ewa M. Goldys y Brant C. Gibson. SPIE, 2019. http://dx.doi.org/10.1117/12.2551712.
Texto completoAfifi, N. A., M. Atef, K. Abo-El-Sooud y N. El-Mokadem. "Effect of Paracetamol on the Pharmacokinetics of Cephalexin in Dogs". En Proceedings of the International Conference on Antimicrobial Research (ICAR2010). WORLD SCIENTIFIC, 2011. http://dx.doi.org/10.1142/9789814354868_0072.
Texto completoForbes, Clarissa, Thai T. H. Nguyen, Richard L. O’Leary y Chris J. Price. "Elucidating the mechanism of paracetamol sonocrystallization for product purity enhancement". En 174th Meeting of the Acoustical Society of America. Acoustical Society of America, 2017. http://dx.doi.org/10.1121/2.0000739.
Texto completoInformes sobre el tema "Paracetamolo"
Paracetamol may be ineffective in treating lower back pain. National Institute for Health Research, julio de 2015. http://dx.doi.org/10.3310/signal-000102.
Texto completoParacetamol is a weak painkiller for regular tension headaches. National Institute for Health Research, septiembre de 2016. http://dx.doi.org/10.3310/signal-000299.
Texto completoDiclofenac or etoricoxib, but not paracetamol, is effective for treating osteoarthritis. National Institute for Health Research, mayo de 2016. http://dx.doi.org/10.3310/signal-000245.
Texto completoParacetamol and alcohol are the most common substances taken by young people and rates of poisoning are increasing. National Institute for Health Research, diciembre de 2018. http://dx.doi.org/10.3310/signal-000694.
Texto completo